InsightRX Nova for Providers

Precision dosing to help deliver safer and more effective treatment.

Nova combines validated pharmacokinetic models with real-time patient data to help clinicians reach therapeutic targets faster and reduce adverse drug events.
  1. Home
  2. MIPD for Providers
  3. InsightRX Nova for Providers

Dosing decisions as individual as your patients

Nova brings Bayesian precision dosing into your existing clinical environment, giving every member of your team the data and recommendations they need to act confidently at the point of care.

Streamlined clinical decision support, built for busy workflows
Access critical patient data and dose recommendations on a single screen, purpose-built for the pace of clinical decision-making.
No more generic dosing calculators
Combine patient-specific data with proven population models to generate personalized regimens that adapt in real time to each patient's evolving clinical data.
Remove the guesswork from dose regimen selection
InsightRX Nova's predictive safety alerts guard against over- and under-dosing, so clinicians can act with confidence.
Fits the workflow your team already uses
Nova is designed to complement existing clinical processes, so pharmacists spend less time navigating systems and more time focused on patients.
Success Story

Hospitals using InsightRX report measurable impact across safety, efficiency, and cost.

Explore one case study that showed:

0 Patients with an AKI after 48 hours

Feature: InsightRX Gemini

The best model for your patient, powered by data.

An evidence-based model guidance engine built directly into Nova. Drawing on nearly 400,000 real-world vancomycin treatment courses, InsightRX Gemini surfaces the best-performing pharmacokinetic model for each patient.

  • Evaluates model performance across patient subpopulations with no manual effort or workload on clinicians
  • Recommends from a catalog of prospectively validated PK models based on your patient's characteristics
  • Shown to improve initial dosing accuracy and reduce prediction bias compared to single-model approaches, even before any drug levels are available
  • Book a demo to see Gemini
InsightRX Nova — Gemini Model Selection Engine
Age: 72 yrs BMI: 31.4 SCr: 1.2 mg/dL Sex: Male
Matching to 384,000+ patient records across 139 subpopulations...
 
 
InsightRX Gemini Selection
Vancomycin adult model (2024)

Get Answers

Frequently Asked Questions

Have questions about MIPD, our platform, or how implementation works? We've put together answers to the questions we hear most often from clinical and pharmacy teams.

Nova currently supports common infectious diseases agents (e.g. vancomycin, aminoglycosides), conditioning agents for bone marrow transplant (e.g. busulfan, fludarabine, thymoglobulin) and a growing list of additional antimicrobials and oncology agents. Browse the current Nova drug module availability, or contact us to discuss your institution's priority therapeutic areas.
Nova integrates with major EHR and pharmacy systems via SMART on FHIR. Integration allows for automated data import into the dosing application. Our implementation team handles the integration and validates data flow before go-live.
Nova uses rigorously validated population pharmacokinetic models drawn from peer-reviewed literature and/or developed in collaboration with leading clinical pharmacologists. All models are curated and reviewed by our scientific team before entry into the Nova application.
Yes, Nova supports institution-defined target ranges, allowing your team to align recommendations with your formulary, patient population, and stewardship policies.
A clinician opens Nova from within the patient encounter, reviews the pre-populated PK profile built from the patient's real data, and receives a model-informed dose assessment. They can adjust inputs, explore alternative regimens, and document the decision, all without leaving the application.
While Nova is optimized for clinical pharmacists, who generally drive drug regimen adjustments/workflows in most institutions, it can be used by any clinician with reasonable knowledge. Physician and prescriber access can be configured based on your team's workflow.
Implementation is managed by InsightRX's dedicated customer success team and typically takes 4–8 weeks, depending on integration complexity and institutional readiness. We handle EHR connectivity, model configuration, staff training and education, and positioning site readiness.
Most pharmacists are proficient within a one or two training sessions. Nova is designed for clinical workflow (not PK modeling expertise), so the learning curve is low even for users without a PK background.
Nova flags missing or stale data clearly within the interface. Pharmacists retain full access to manual data entry, so patient care is never blocked by a feed issue or EHR downtime.

Maximize therapeutic success with precision medicine.

Contact Us